J&J plans late-stage trial for lupus candidate after Phase 2 success

FierceBiotechGLP-1s may combat depression by multiplying a mood-boosting gut microbe

Endpoints NewsSonoThera raises $125M for non-viral gene therapy approach

BioPharma DiveParabilis sets a record with a $670M biotech IPO

FierceBiotechBig Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery

Clinical OMICsGLP-1s May Benefit Mental Health Through Gut–Brain Axis

Clinical OMICsPhase Ib/IIa for Hepatitis B Epigenetic Silencer Shows Best-in-Class Potential

FierceBiotechEthyreal Bio manifests with $101M in pack of biotechs gunning for Amgen’s Tepezza

Endpoints NewsShattuck raises $75M; Servier inks neuro ASO pact with n-Lorem Foundation

Endpoints NewsBiotech pay analysis: 12 execs with $35M+ M&A golden parachutes

BioPharma DiveAstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine

FierceBiotechNovartis sticks 2nd deal with molecular glue biotech Orionis, this one worth up to $1.4B

BioWorldShenzhen Chipscreen Biosciences synthesizes new HDAC inhibitors